Cresco Labs (CRLBF) Accumulated Expenses (2020 - 2026)

Cresco Labs' Accumulated Expenses history runs 7 years deep, the most recent figure standing at $55.0 million for Q1 2026.

• Quarterly Accumulated Expenses fell 1.98% year-over-year to $55.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.0 million (down 1.98% YoY) and the FY2025 annual result came in at $58.0 million, up 6.85% from the prior year.
• Accumulated Expenses was $55.0 million for Q1 2026 at Cresco Labs, down from $58.0 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $96.0 million in Q1 2022 and bottomed at $50.1 million in Q3 2025.
• A 5-year average of $60.9 million and a median of $56.1 million in 2025 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2024 — Accumulated Expenses slipped 21.4% — and 2025, when it rose 6.85%.
• Cresco Labs' Accumulated Expenses stood at $96.0 million in 2022, then dropped by 28.01% to $69.1 million in 2023, then slipped by 21.4% to $54.3 million in 2024, then increased by 6.85% to $58.0 million in 2025, then decreased by 5.14% to $55.0 million in 2026.
• Business Quant data shows CRLBF's Accumulated Expenses at $55.0 million in Q1 2026, $58.0 million in Q4 2025, and $50.1 million in Q3 2025.